Sheng Changting, Yue Rensong
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
J Ethnopharmacol. 2025 Apr 9;345:119338. doi: 10.1016/j.jep.2025.119338. Epub 2025 Jan 16.
Di Dang Tang is a classic formula from Shang Han Lun, originally used to treat conditions such as blood stasis and heat accumulation. It is widely applied in the treatment of diabetes and its complications, but its effects on Type 2 Diabetes Mellitus-related Cognitive Dysfunction (T2DM-CD) remain unclear.
The study aimed to investigate the metabolic characteristics of patients with T2DM-CD. Additionally, it sought to evaluate the effects of Di Dang Tang on cognitive function in T2DM-CD model rats by targeting the metabolic pathways identified in the clinical analysis, exploring the underlying mechanisms through animal experiments.
Fasting venous serum was collected from patients with Type 2 Diabetes Mellitus (T2DM) to detect metabolism-related products, and KEGG annotation analysis was performed. Separately, thirty rats were randomly divided using a random number table method, with six rats selected as the blank control group. Twenty-four successfully modeled rats were then randomly divided into the model group and three Di Dang Tang groups (low, medium, and high doses). After administering the medication, the relevant indicators in the rats were assessed.
Clinical metabolomics detected 32 key differential metabolites between the T2DM-CD and the blank control groups. Between the T2DM-CD and T2DM groups, 29 key differential metabolites were identified. In animal experiments, blood glucose levels in the model group were significantly higher compared to the blank control group at the same time points, whereas the high dose groups of Di Dang Tang exhibited reduced blood glucose levels at weeks 6 and 8 relative to the model group. In the Morris water maze test, the model group had longer escape latencies than the blank control group. The medium and high dose groups of Di Dang Tang showed shorter latencies. Additionally, compared to the model group, the Di Dang Tang groups spent more time and covered more distance in the target quadrant but had reduced average proximity and fewer platform entries. HE staining observation of the hippocampal CA1 area showed no apparent pathological changes in the blank group, obvious pathological damage in the model group, and no significant pathological changes in the medium and high dose groups of Di Dang Tang. Compared to the blank control group, the model group showed significant increases in the levels of Arachidonic Acid (AA), Ceramide (Cer), Glutamate (Glu), TNF- α, IL-1β, TG, and LDL-C, and a significant decrease in HDL-C levels. Compared to the model group, the groups of Di Dang Tang significantly modulated the levels of the above indicators. In Western Blot (WB) assays, compared to the blank control group, the model group rats exhibited significantly higher levels of cPLA2, PKC, ERK, and JNK , and significantly lower levels of claudin-5, NMDA, CaMKII, CREB, and BDNF. The Di Dang Tang groups significantly altered the levels of the above indicators compared to the model group.
Amino acid metabolism, sphingolipid signaling pathways, glycerophospholipid metabolism, and various signaling pathways play significant roles in the pathogenesis of T2DM-CD. Di Dang Tang can improve learning and memory abilities in T2DM model rats and ameliorate cognitive impairments, potentially by regulating metabolic levels and inflammatory responses.
抵当汤是《伤寒论》中的经典方剂,最初用于治疗血瘀、热结等病症。它被广泛应用于糖尿病及其并发症的治疗,但其对2型糖尿病相关认知功能障碍(T2DM-CD)的作用仍不清楚。
本研究旨在调查T2DM-CD患者的代谢特征。此外,通过针对临床分析中确定的代谢途径,评估抵当汤对T2DM-CD模型大鼠认知功能的影响,并通过动物实验探索其潜在机制。
收集2型糖尿病(T2DM)患者的空腹静脉血清以检测代谢相关产物,并进行KEGG注释分析。另外,采用随机数字表法将30只大鼠随机分组,选取6只大鼠作为空白对照组。然后将24只成功造模的大鼠随机分为模型组和三个抵当汤组(低、中、高剂量)。给药后,评估大鼠的相关指标。
临床代谢组学检测发现T2DM-CD组与空白对照组之间有32种关键差异代谢物。T2DM-CD组与T2DM组之间,鉴定出29种关键差异代谢物。在动物实验中,模型组在相同时间点的血糖水平显著高于空白对照组,而抵当汤高剂量组在第6周和第8周相对于模型组血糖水平降低。在Morris水迷宫试验中,模型组的逃避潜伏期比空白对照组更长。抵当汤中、高剂量组的潜伏期较短。此外,与模型组相比,抵当汤组在目标象限花费的时间更多、游动距离更远,但平均接近度降低且平台穿越次数减少。海马CA1区的HE染色观察显示,空白组无明显病理变化,模型组有明显病理损伤,抵当汤中、高剂量组无明显病理变化。与空白对照组相比,模型组的花生四烯酸(AA)、神经酰胺(Cer)、谷氨酸(Glu)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)水平显著升高,高密度脂蛋白胆固醇(HDL-C)水平显著降低。与模型组相比,抵当汤组显著调节了上述指标的水平。在蛋白质免疫印迹(WB)分析中,与空白对照组相比,模型组大鼠的胞浆型磷脂酶A2(cPLA2)、蛋白激酶C(PKC)、细胞外信号调节激酶(ERK)和c-Jun氨基末端激酶(JNK)水平显著升高,而紧密连接蛋白5(claudin-5)、N-甲基-D-天冬氨酸受体(NMDA)、钙/钙调蛋白依赖性蛋白激酶Ⅱ(CaMKII)、环磷腺苷效应元件结合蛋白(CREB)和脑源性神经营养因子(BDNF)水平显著降低。与模型组相比,抵当汤组显著改变了上述指标的水平。
氨基酸代谢、鞘脂信号通路、甘油磷脂代谢和各种信号通路在T2DM-CD的发病机制中起重要作用。抵当汤可改善T2DM模型大鼠的学习和记忆能力,减轻认知障碍,可能是通过调节代谢水平和炎症反应实现的。